LAB — STANDARD BIOTOOLS INC

Ownership history in Casdin Capital, LLC  ·  11 quarters on record

This page tracks every 13F SEC filing in which Casdin Capital, LLC reported a position in STANDARD BIOTOOLS INC (LAB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
12.47% (2024 Q1)
Avg. % of fund
6.36%
First filed
2023 Q2
Last filed
2025 Q4
Quarters held
11
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 88,783,856 +11,225,000 +14.5% 7.06% $113.6M $1.28
2025 Q3 ADDED 77,558,856 +1,483,220 +1.9% 8.41% $100.8M $1.30
2025 Q2 UNCHANGED 76,075,636 — 0% 8.31% $91.3M $1.20
2025 Q1 ADDED 76,075,636 +4,820,959 +6.8% 6.71% $82.2M $1.08
7 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    LAB price (monthly, adj. close)

Other funds also holding LAB

As of 2025 Q4 — sorted by position size

MAK CAPITAL ONE LLC 3Y 7Y 2.72% Nan Fung Group Holdings Ltd 3Y 2.16% Hollow Brook Wealth Management LLC 3Y 7Y 1.84% Tikvah Management LLC 3Y 7Y 1.21% Long Focus Capital Management, LLC 3Y 0.43% QVIDTVM Management LLC 3Y 0.33% VIKING GLOBAL INVESTORS LP 3Y 7Y 0.2% Intellectus Partners, LLC 3Y 7Y 0.1% JOHNSON & JOHNSON 3Y 0.07% Amova Asset Management Americas, Inc. 3Y 7Y 0.06%
← Back to Casdin Capital, LLC Holdings